Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1237
| Despition | CRMP1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1370 | EFEMP1 Blocking Peptide (AC1370) | 250 µg | inquiry |
| ACPP-1423 | Human ALDH5A1 Protein (AC1423) | 2 µg | inquiry |
| ACPP-1563 | Human STX4 Protein (AC1563) | 5 µg | inquiry |
| ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg | inquiry |
| ACPP-1752 | Human ASPA Protein (AC1752) | 5 µg | inquiry |
| ACPP-1490 | SOX10 Blocking Peptide (AC1490) | 250 µg | inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1609 | Human CNTF Protein, His (AC1609) | 5 µg | inquiry |
| ACPP-1497 | Human AMIGO2 Protein (AC1497) | 2 µg | inquiry |
| ACPP-1061 | Recombinant Human DLK-1 Protein (Fc Tag) (AC1061) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.